Web Version

Dear Researcher,

ClearColi™ cells are the first commercially available competent cells with a modified LPS that virtually eliminates endotoxic response.
ClearColi cells lack outer membrane agonists for hTLR4/MD-2 activation, eliminating this response compared with E. coli wild-type cells.

ClearColi BL21(DE3) Electrocompetent Cells

  • Protein expression, plasmid production and phage display
  • Human cell immunogenicity and toxicity assays
  • Therapeutic protein production
  • Membrane and lipid-binding protein production

ClearColi K-12 Electrocompetent Cells

  • Cloning and plasmid production
  • Mammalian transfection without endotoxin cleanup
  • Transient protein expression
  • Plasmid yields similar to DH10B cells
BioCat GmbH

Im Neuenheimer Feld 584
D-69120 Heidelberg
Tel:  +49 (0) 6221 7141516
Fax: +49 (0) 6221 7141529
Email: info@biocat.com
Web: http://www.biocat.com